Skip to main content
TipRanks
Go Ultimate75% OFF

SELLAS Life Sciences Group (RXK3) Q4 2020 Earnings Report

2 Followers

DE:RXK3 Q4 2020 EPS Results

Actual EPS
-EUR 0.39
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 8.42

DE:RXK3 Q4 2020 Revenue Results

Actual Revenue
EUR 1.73M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2020
Date
03/23/2021
Time
After Close
Conference Call
Tuesday, March 23, 2021
DE:RXK3 Upcoming Earnings

SELLAS Life Sciences Group's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q4 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:RXK3 Earnings History

DE:RXK3 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.05--0.05――
Nov 12, 20262026 (Q3)-0.05-0.05-0.0516.67% (+0.01)
Aug 11, 20262026 (Q2)-0.04-0.05-0.0628.57% (+0.02)
May 12, 20262026 (Q1)-0.05-0.05-0.0628.57% (+0.02)
Mar 19, 20262025 (Q4)-0.06-0.05-0.0516.67% (+0.01)
Nov 12, 20252025 (Q3)-0.07-0.05-0.0940.00% (+0.04)
Aug 12, 20252025 (Q2)-0.07-0.06-0.1246.15% (+0.05)
May 13, 20252025 (Q1)-0.10-0.06-0.1966.67% (+0.13)
Mar 20, 20252024 (Q4)-0.10-0.05-0.2173.91% (+0.15)
Nov 13, 20242024 (Q3)-0.12-0.09-0.369.70% (+0.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed